Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD15 is a risk predictor and a novel target in clear cell renal cell carcinoma.
Stenzel PJ, Schindeldecker M, Seidmann L, Herpel E, Hohenfellner M, Hatiboglu G, Foersch S, Porubsky S, Macher-Goeppinger S, Roth W, Tagscherer KE. Stenzel PJ, et al. Among authors: tagscherer ke. Pathobiology. 2023 Nov 14. doi: 10.1159/000535201. Online ahead of print. Pathobiology. 2023. PMID: 37963432
Lamin-B1 is a senescence-associated biomarker in clear-cell renal cell carcinoma.
Radspieler MM, Schindeldecker M, Stenzel P, Försch S, Tagscherer KE, Herpel E, Hohenfellner M, Hatiboglu G, Roth W, Macher-Goeppinger S. Radspieler MM, et al. Among authors: tagscherer ke. Oncol Lett. 2019 Sep;18(3):2654-2660. doi: 10.3892/ol.2019.10593. Epub 2019 Jul 9. Oncol Lett. 2019. PMID: 31402955 Free PMC article.
Prognostic and Predictive Value of Tumor-infiltrating Leukocytes and of Immune Checkpoint Molecules PD1 and PDL1 in Clear Cell Renal Cell Carcinoma.
Stenzel PJ, Schindeldecker M, Tagscherer KE, Foersch S, Herpel E, Hohenfellner M, Hatiboglu G, Alt J, Thomas C, Haferkamp A, Roth W, Macher-Goeppinger S. Stenzel PJ, et al. Among authors: tagscherer ke. Transl Oncol. 2020 Feb;13(2):336-345. doi: 10.1016/j.tranon.2019.11.002. Epub 2019 Dec 24. Transl Oncol. 2020. PMID: 31881506 Free PMC article.
Prognostic relevance of androgen receptor expression in renal cell carcinomas.
Foersch S, Schindeldecker M, Keith M, Tagscherer KE, Fernandez A, Stenzel PJ, Pahernik S, Hohenfellner M, Schirmacher P, Roth W, Macher-Goeppinger S. Foersch S, et al. Among authors: tagscherer ke. Oncotarget. 2017 Sep 11;8(45):78545-78555. doi: 10.18632/oncotarget.20827. eCollection 2017 Oct 3. Oncotarget. 2017. PMID: 29108248 Free PMC article.
Nivolumab Reduces PD1 Expression and Alters Density and Proliferation of Tumor Infiltrating Immune Cells in a Tissue Slice Culture Model of Renal Cell Carcinoma.
Stenzel PJ, Hörner N, Foersch S, Wagner DC, Tsaur I, Thomas A, Haferkamp A, Macher-Goeppinger S, Roth W, Porubsky S, Tagscherer KE. Stenzel PJ, et al. Among authors: tagscherer ke. Cancers (Basel). 2021 Sep 8;13(18):4511. doi: 10.3390/cancers13184511. Cancers (Basel). 2021. PMID: 34572738 Free PMC article.
Decoy receptor 3 is a prognostic factor in renal cell cancer.
Macher-Goeppinger S, Aulmann S, Wagener N, Funke B, Tagscherer KE, Haferkamp A, Hohenfellner M, Kim S, Autschbach F, Schirmacher P, Roth W. Macher-Goeppinger S, et al. Among authors: tagscherer ke. Neoplasia. 2008 Oct;10(10):1049-56. doi: 10.1593/neo.08626. Neoplasia. 2008. PMID: 18813347 Free PMC article.
Prognostic value of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors in renal cell cancer.
Macher-Goeppinger S, Aulmann S, Tagscherer KE, Wagener N, Haferkamp A, Penzel R, Brauckhoff A, Hohenfellner M, Sykora J, Walczak H, Teh BT, Autschbach F, Herpel E, Schirmacher P, Roth W. Macher-Goeppinger S, et al. Among authors: tagscherer ke. Clin Cancer Res. 2009 Jan 15;15(2):650-9. doi: 10.1158/1078-0432.CCR-08-0284. Clin Cancer Res. 2009. PMID: 19147771
40 results